Konstantin A. Pishchulov

Konstantin A. Pishchulov

Auto-generated profile, based on publicly available information

Konstantin A. Pishchulov

World-Class Research Center "Center for Personalized Medicine", Almazov National Medical Research Center; Napalkov Clinical Scientific and Practical Center of Specialized Types of Medical Care (Oncology)

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
SMSimakova Maria
Simakova Maria
PKPishchulov Konstantin
Pishchulov Konstantin
LVLukinov Vitaliy
Lukinov Vitaliy
VNVoynov Nikita
Voynov Nikita
BMBulaeva Maria
Bulaeva Maria
SKSamochernykh Konstantin
Samochernykh Konstantin
Introduction: Postoperative venous thromboembolism (VTE) is a frequently occurring complication among glioma patients. Several risk assessment models (RAMs), including the Caprini RAM, the IMPROVE Risk Score, the IMPROVED VTE Risk Score, and the Padua Prediction Score, have not been validated within the glioma patient population. The purpose of this study was to assess the predictive accuracy of established VTE risk scales in patients with glioma. Materials and Methods: A single-center, retrospective, observational cohort study was conducted on 265 glioma patients who underwent surgery at the Almazov Medical and Research Centre between 2021 and 2022. VTE detection followed the current clinical guidelines. Threshold values for the Caprini, IMPROVE VTE, IMPROVEDD, and Padua scales were determined using ROC analysis methods, with cumulative weighting for sensitivity and specificity in predicting VTE development. The areas under the ROC curves (AUC) were calculated, and comparisons were made using the DeLong test. Results: The area under the curve for the Caprini risk assessment model was 80.41, while the IMPROVEDD VTE risk score was 75.38, the Padua prediction score was 76.9, and the IMPROVE risk score was 72.58. No significant differences were observed in the AUC values for any of the scales. The positive predictive values of all four scales were low, with values of 50 (28–72) for Caprini, 48 (28–69) for IMPROVEDD VTE, 50 (30–70) for Padua, and 64 (35–87) for IMPROVE RAM. No significant differences were found in terms of PPV, NPV, positive likelihood ratio, and negative likelihood ratio among the analyzed scales. Conclusions: The Caprini Risk Assessment Model, the IMPROVE Risk Score, the IMPROVED VTE Risk Score, and the Padua Prediction Score exhibit acceptable specificity and sensitivity for glioma patients. However, their low positive predictive ability, coupled with the complexity of interpretation, limits their utility in neurosurgical practice.

20 November 2023 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
MOMelnichnikova Olga
Melnichnikova Olga
ZYZhilenkova Yuliya
Zhilenkova Yuliya
Vitaliy Leonidovich LukinovVitaliy Leonidovich Lukinov
Vitaliy Leonidovich Lukinov
ZEZolotova Ekaterina
Zolotova Ekaterina
PKPishchulov Konstantin
Pishchulov Konstantin
VTVavilova Tatyana
Vavilova Tatyana

16 April 2026 in Russian Journal of Cardiology
Verified
Journal Article
Closed access
KPK. A. Pishchulov
K. A. Pishchulov
MSM. A. Simakova
M. A. Simakova
Vitaliy Leonidovich LukinovVitaliy Leonidovich Lukinov
Vitaliy Leonidovich Lukinov
NVN. E. Voynov
N. E. Voynov
SSS. S. Sklyar
S. S. Sklyar
ESE. V. Shlyakhto
E. V. Shlyakhto
Aim . To develop and validate a model for venous thromboembolism (VTE) risk assessment during the inpatient antitumor treatment in patients with central nervous system glial tumors. Material and methods . The retrospective group included 186 patients whose data were obtained from the heath information system for the period 2019-2021 and used to develop the model. The testing sample consisted of 111 patients prospectively enrolled in the study. The model was validated on an external sample of 56 patients with gliomas. The model was constructed using multivariate logistic regression. Results . The resulting model for VTE risk assessment included the follo­wing risk factors: central paresis of one or both lower extremities, which is a manifestation of focal neurological deficit caused by the tumor; elevated D-dimer; decreased absolute platelet count; age over 63 years; and a history of radiation therapy. The area under the curve of the resulting model was 90,8% in the training sample, 82,9% in the testing sample, and 79,3% in the external validation sample. Conclusion . The developed and tested VTE risk model for inpatient period in patients with gliomas appears promising for subsequent clinical trials evaluating the effectiveness of personalized thromboprophylaxis.

30 June 2023 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
KPK.A. Pishchulov
K.A. Pishchulov
MSM.A. Simakova
M.A. Simakova
Vitaliy Leonidovich LukinovVitaliy Leonidovich Lukinov
Vitaliy Leonidovich Lukinov
SPS.I. Parkhomenko
S.I. Parkhomenko
NVN.E. Voinov
N.E. Voinov
OMOlga Moiseeva
Olga Moiseeva
Background: Ranking third in the cause of death structure, venous thromboembolism (VTE) is a frequent complication in patients with central nervous system tumors.Objective: To assess the incidence of venous thrombosis and its risk factors in glioma patients based on retrospective data.Methods: Our retrospective study included 186 glioma patients from the Neurosurgery Department of Almazov National Medical Research Centre.Results: The VTE incidence was 8% in patients with brain neoplasms. Comparative analysis of 2 groups to identify VTE predictors showed that the probability of thrombosis increases with factors leading to the patient immobilization: altered mental status (40% [n = 6] in the VTE group vs 18% [n = 30] in the non-VTE group, OR: 3.1 [95% СI: 0.8–10.6], P = .080), neurological deficit (67% [n = 50] vs 29% [n = 10], OR: 4.8 [95% СI: 1.4–18.7], P = .007), and bed rest for more than 3 days (33% vs 4%, OR: 13.1 [95% СI: 2.7–62.8], P < .001). Based on the validation results, Caprini and IMPROVEDD risk scores have high negative predictive values: 0.99 [95% СI: 0.93–1.00] vs 0.97 [95% СI: 0.93–0.99] (P = .317). Caprini risk score has a specificity of 48.2% and a sensitivity of 93.3% (AUC = 78.98); the threshold value for high-risk VTE detection is 5.5 points. IMPROVEDD risk score has a specificity of 82.5% and a sensitivity of 73.3% (AUC = 81.1); the threshold value for high-risk VTE detection is 4.5 points.Conclusion: Our study revealed VTE risk factors in glioma patients, such as neurological deficit, prolonged bed rest (more than 3 days), and a high-grade tumor. We demonstrated high negative predictive values of Caprini and IMPROVEDD risk scores and determined their threshold values to be validated in a further prospective study. Due to the high incidence of VTE and risks of hemorrhage in patients with central nervous system tumors, personalized venous thrombosis risk calculators should be developed, providing for features of thrombosis pathogenesis in this patient group. Received 12 December 2022. Revised 7 April 2023. Accepted 31 May 2023. Funding: The study was supported by Ministry of Science and Higher Education of Russian Federation (No. 075-15-2022-301). Conflict of interest: The authors declare no conflict of interest. Contribution of the authorsConception and study design: K.A. Pishchulov, M.A. SimakovaData collection and analysis: K.A. Pishchulov, S.I. ParkhomenkoStatistical analysis: V.L. LukinovDrafting the article: K.A. Pishchulov, M.A. Simakova, V.L. Lukinov, S.I. Parkhomenko, N.E. Voinov, S.S. Sklyar, O.M. MoiseevaCritical revision of the article: K.A. Pishchulov, M.A. Simakova, V.L. Lukinov, S.I. Parkhomenko, N.E. Voinov, S.S. Sklyar, O.M. MoiseevaFinal approval of the version to be published: K.A. Pishchulov, M.A. Simakova, V.L. Lukinov, S.I. Parkhomenko, N.E. Voinov, S.S. Sklyar, O.M. Moiseeva

28 June 2024
Verified
Book Chapter
Closed access
PDF file
SLSergei Leontev
Sergei Leontev
MSMaria Simakova
Maria Simakova
Vitaliy Leonidovich LukinovVitaliy Leonidovich Lukinov
Vitaliy Leonidovich Lukinov
KPKonstantin Pishchulov
Konstantin Pishchulov
IDIlia Derevitskii
Ilia Derevitskii
AVAleksandra Vatian
Aleksandra Vatian

1 October 2020 in Pulmonary Circulation
Verified
Journal Article
Open access
MSMaria A. Simakova
Maria A. Simakova
DKDaria V. Karpova
Daria V. Karpova
NMNarek V. Marukyan
Narek V. Marukyan
KPKonstantin A. Pishchulov
Konstantin A. Pishchulov
EMEvgeny N Mikhaylov
Evgeny N Mikhaylov
OMOlga M. Moiseeva
Olga M. Moiseeva
A 58-year-old male patient with multi-vessel pulmonary vein (PV) stenosis following atrial fibrillation ablation was referred to a specialized pulmonary hypertension clinic. Chest dual-energy computed tomography (CT)-angiography allowed precise diagnosis of two PVs occlusion and three PVs significant stenosis. Iodine maps showed perfusion deficiency and its value for each stenosis, determining the sequence of multiple PV interventions. We suggest iodine CT mapping is a useful tool in the definition of PV stenosis severity and planning staged angioplasty.